Improved procurement pact sought

A two-man delegation from the World Trade Organization that specializes in government procurement agreements arrived in Israel on Sunday to conduct a seminar on the subject over the next two days.

By AVI KRAWITZ
January 29, 2007 07:30

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

A two-man delegation from the World Trade Organization that specializes in government procurement agreements (GPA) arrived in Israel on Sunday to conduct a seminar on the subject over the next two days. The Ministry of Industry, Trade and Labor said the seminar forms part of its foreign trade management's efforts to improve the GPAs currently being negotiated at the WTO in Geneva. The GPA will be signed by 37 countries, formulating the requirements for the performance of government company tenders, obligating the signatories to set standards of transparency in carrying out the tenders.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS